Veterinary Infusion Pumps Market Size was prized at USD 0.104 Billion in 2023. The veterinary infusion pumps market industry is projected to grow from USD 0.108 Billion in 2024 to USD 0.15 Billion by 2032, displaying a compound annual growth rate of 4.07% between 2024 and 2032. The rise in zoonotic diseases (diseases spread from animal to human), pet ownership, the demand for meat and other animal-based products, and the use of animals in agriculture are the key market drivers fostering the growth of the market. Additionally, the market for veterinary infusion pumps is expected to expand during the projected period due to the accessibility and affordability of treatments and expanding technical advances.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
In June 2023, B. Braun Medical Inc. (B. Braun), a prominent player in smart infusion therapy, unveiled its latest infusion management software, known as DoseTrac® Enterprise Infusion Management Software. This new software provides businesses with a combination of real-time views and retrospective reporting options, enabling them to gain a deeper understanding of their infusion pump fleet and the accompanying data. The DoseTrac Enterprise Software platform has the capability to link up to 40,000 pumps across an unlimited number of facilities using a single application. DoseTrac Enterprise enables customers to efficiently oversee their infusion pumps through a unified central application, irrespective of the scale of their fleet or the number of sites. Pumps have the ability to transition smoothly between different places, while data can be collected and separated from the overall enterprise level to the specific facility care area. This aids in the ongoing enhancement of quality. DoseTrac can help improve data management which may lead to a decrease in clinical IT infrastructure required for infusion pumps.
Market CAGR for veterinary infusion pumps is driven by the rising number of animal surgeries. The market for veterinary infusion pumps is anticipated to grow due to the rise in the number of surgeries performed on pets. A surgical procedure is a medical act that entails cutting a living organism with tools to treat an illness or repair damage. Using the equipment for incision, dissection, and wound closure, veterinary surgical instruments enable surgeons to undertake surgery. For instance, in 2021, the total number of spay-neuter procedures performed on dogs and cats in the US increased by 11.78%, from 1,059,388 in 2020 to 1,184,274 in 2021, according to the National Library of Medicine, a biomedical library situated in the US. As a result, the market for veterinary infusion pumps is driven by the rising cost of healthcare.
Increased demand for approved novel immunotherapies and targeted therapies, which are highly effective for treating cancers in pets, as well as rising cancer prevalence and relapse rates among animals, are some factors boosting the growth of the veterinary infusion pump market. Dogs are more likely than other companion animals to develop cancer. The Veterinary Cancer Society reports that in 32% of cats and 47% of dogs, particularly those over the age of 10, cancer is the primary cause of death. Compared to cats, dogs have cancer at a rate roughly equal to that of humans. In a study conducted by PetMD, LLC, it was discovered that 95% of dogs that had chemotherapy for lymphoma went on to have illness relapse or remission. In 50% of dog species, the remission lasts fewer than 15 months. Despite the relapse rate linked to these drugs, veterinarians advise other therapies approved for the treatment of canine cancer and are anticipated to produce additional revenue for market participants.
Throughout the history of veterinary infusion, technology related to infusion pumps has continuously advanced on several occasions. To manage and monitor the flow of fluids to patients and give drugs via transfusion, incredibly sophisticated and hassle-free technologies have been developed. Companies are concentrating on creating innovative infusion pumps with user-friendly and portable devices to simplify the utility and operation of these pumps to increase performance and reliability. Thus, driving the veterinary infusion pumps market revenue.
The veterinary infusion pumps market segmentation, based on type, includes syringe infusion pumps and large-volume infusion pumps. The large-volume infusion pump segment dominated the market, accounting for 59.5% of market revenue (0.1 Billion) due to the growing use of these devices for parenteral nutrition administration, emergencies, and fluid delivery to animals undergoing blood transfusions. These pumps' weight, technology, accuracy, flow rate, battery life, and type of infusion (continuous, intermittent) can be manually or automatically operated.
February 2021: B. Braun Medical Inc. has announced that its Infusomat Space Large Volume Pump has been named Best in KLAS for Traditional Smart Pumps for 2021. The Best in KLAS awards are presented by KLAS Research, a prominent healthcare research and insights business, and are based on side-by-side performance comparisons and input from healthcare providers across the United States.
However, during the projected period, the syringe infusion pumps category is anticipated to increase at the greatest CAGR. This is linked to the use of syringe infusion pumps, which has increased due to technological developments in the field.
Figure 1: Veterinary Infusion Pumps Market, by Type, 2022 & 2032 (USD Billion)
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The veterinary infusion pumps market segmentation, based on end-user, includes veterinary hospitals, veterinary clinics, and others. In 2022, the veterinary hospital industry ruled the entire world. The increase in veterinary facilities to treat animals due to increased animal diseases was blamed for this. However, during the projected period, the veterinary clinic's category is anticipated to develop at the greatest CAGR. This is linked to the availability of veterinary services and the rapid expansion of veterinary clinics to treat animals.
By region, the report gives market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American veterinary infusion pumps market area will dominate this market. A growing emphasis on improving and advancing animal healthcare technologies, greater research and development operations, and favorable government reimbursement rules for pet insurance are all credited with the region's rise.
Further, the major countries studied in the market report are US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil.
Figure 2: VETERINARY INFUSION PUMPS MARKET SHARE BY REGION 2022 (USD Billion)
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Europe’s veterinary infusion pumps market accounts for the second-largest market share. Increased healthcare spending in the area and an increase in the prevalence of animal illnesses, and government measures for animal welfare are driving market expansion. Further, the German veterinary infusion pumps market held the largest market share, and the UK veterinary infusion pumps market was the rapidly growing market in the European region.
The Asia-Pacific Veterinary Infusion Pumps Market is expected to grow at a rapid rate from 2023 to 2032. Important players in the area are responsible for the market growth in this area. Additionally, the industry is expanding due to the surge in the adoption of companion animals. Australia has one of the greatest ownership of pets rates in the world. For instance, the Australian Companion Animal Health Foundation estimates that there are over 24 million companion animals in Australia, with many homes having multiple pets. Moreover, China’s veterinary infusion pumps market held the largest market share, and the Indian veterinary infusion pumps market was the rapidly growing market in the Asia-Pacific region.
Veterinary Infusion Pumps Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the veterinary infusion pumps market, grow even more. To increase their worldwide footprint, market participants are also engaging in various strategic actions. Important market developments include introducing new products, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the veterinary infusion pump industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the veterinary infusion pump industry to benefit clients and increase the market sector. In recent years, the veterinary infusion pump industry has offered some of the most significant advantages to medicine. Major players in the veterinary infusion pumps market, including Vetland Medical Sales & Services LLC (US), Q Core Medical Ltd (Israel), Braun Melsungen AG (Germany), Leading Edge Veterinary Equipment, Inc. (US)., and others, are attempting to increase market demand by investing in research and development operations.
Hawk Medical (Hawkmed), founded in 2004, is a leading company that focuses on innovating and developing one-stop infusion system solutions and medical accessory solutions such as infusion pumps, syringe pumps, enteral feeding pumps, fluid warmer, infusion workstations, infusion disposables, patient monitoring accessories, medical imaging accessories, and so on. Hawkmed maintains cutting-edge technologies through continuous R&D investment, allowing it to supply accurate and efficient medical solutions to the healthcare business. In May 2022, Hawkmed, a medical device manufacturer, introduced its newest product, the TOUCH-SCREEN Veterinary Infusion Pump-HK-T100VET. This new infusion pump improves their previous veterinary pump, the HK-100VET, and features a 3.5-inch TOUCH-SCREEN with an interactive user interface. This advancement improves the user experience for veterinary professionals who deliver infusion therapy to animals.
Eitan Medical is rethinking drug delivery, putting patients at the center of care and making drug delivery easier and safer than ever before. Eitan Medical goes beyond patient safety and care, intuitive drug delivery and infusion solutions designed to improve patient and clinician quality of life across the continuum of care, including ambulatory, hospital, and home care settings. In January 2021, Eitan Medical announced that its improved SapphireTM infusion pump system software Rev15, which comprises the infusion pump, administration sets, and accessories, has gained 510(k) clearance from the US Food and Drug Administration (FDA).
Key Companies in the veterinary infusion pumps market include
Vetland Medical Sales & Services LLC (US)
Jørgen Kruuse A/S (Denmark)
Braun Melsungen AG (Germany)
Burtons Medical Equipment Ltd (UK)
Q Core Medical Ltd (Israel)
DRE Veterinary (US)
SAI Infusion Technologies (US)
Heska Corporation (US)
Grady Medical Systems (US)
Leading Edge Veterinary Equipment, Inc. (US)
Veterinary Infusion Pumps Industry Developments
December 2022: The Indian government implemented the National Livestock Health and Disease Control Programme (LHDCP). The program aims to reduce risks to animal health by implementing prophylactic vaccination against animal diseases, increasing veterinary service capacity, improving disease surveillance, strengthening veterinary infrastructure, and providing essential healthcare equipment in hospitals.
October 2022: Symmetry Surgical was acquired for an undisclosed sum by Aspen Surgical Products, Inc., a full-service veterinary hospital in the United States. Aspen will be able to expand into more desirable adjacent categories, add more clinically favored goods to its already formidable portfolio, and develop new commercial capabilities and routes to market in both acute and non-acute care settings due to its acquisition of Symmetry. Symmetry Surgical is a surgical instrumentation and solutions company in the United States.
Syringe Infusion Pump
Large-Volume Infusion Pump
Veterinary Hospitals
Veterinary Clinics
Others
North America
Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.104 Billion |
| Market Size 2024 | USD 0.108 Billion |
| Market Size 2032 | USD 0.15 Billion |
| Compound Annual Growth Rate (CAGR) | 4.07% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Market Competitive Landscape, Revenue Forecast, Growth Factors, and Trends |
| Segments Covered | Type and End-User |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil. |
| Key Companies Profiled | Vetland Medical Sales & Services LLC (US), Q Core Medical Ltd (Israel), Braun Melsungen AG (Germany), and Leading Edge Veterinary Equipment, Inc. (US). |
| Key Market Opportunities | The launch of new products will determine the future. |
| Key Market Dynamics | Increase in animal adoption and animal health expenditure |
Veterinary Infusion Pumps Market Highlights:
Frequently Asked Questions (FAQ) :
The market size of the veterinary infusion pumps market was valued at USD 0.104 Billion in 2023.
The worldwide market is forecast to expand at a CAGR of 4.07% from 2024 to 2032.
North America had the largest share of the market.
The leading players in the market are Vetland Medical Sales & Services LLC (US), Q Core Medical Ltd (Israel), Braun Melsungen AG (Germany), and Leading Edge Veterinary Equipment, Inc. (US).
The large-volume infusion pump category dominated the market in 2023.
The veterinary hospital sector had the largest share of the market.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
